Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 591 entries
View as:

Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT02015819 Org: User:
Start: 10/07/14 End: 10/07/17 Due: 10/07/18

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03354728 Org: User:
Start: 05/11/18 End: 12/11/26 Due: 12/11/27

Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05869682 Org: User:
Start: 07/09/24 End: 12/01/27 Due: 12/01/28

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05428176 Org: User:
Start: 02/16/23 End: 06/30/27 Due: 06/30/28

Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT02288416 Org: User:
Start: 12/08/14 End: 09/06/18 Due: 09/06/19

8-Chloroadenosine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02509546 Org: User:
Start: 09/02/15 End: 03/16/21 Due: 03/16/22

Survivorship Booklets With or Without Individual Telephone Sessions in Increasing Knowledge About the Impact of Breast Cancer in African American and Latina Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00932997 Org: User:
Start: 10/31/06 End: 06/30/10 Due: 06/30/11

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00182793 Org: User:
Start: 07/31/05 End: 10/31/14 Due: 10/31/15

Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01074060 Org: User:
Start: 04/30/10 End: 02/28/13 Due: 02/28/14

Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02830594 Org: User:
Start: 10/05/16 End: 01/16/24 Due: 01/16/25

CCI-779 in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00022464 Org: User:
Start: 06/30/01 End: 09/30/05 Due: 09/30/06

Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01627535 Org: User:
Start: 05/31/13 End: 01/31/16 Due: 01/31/17

Cytomegalovirus Vaccine in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT00712634 Org: User:
Start: 11/30/97 End: 04/30/09 Due: 04/30/10

Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01254734 Org: User:
Start: 04/30/11 End: 11/30/14 Due: 11/30/15

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05672342 Org: User:
Start: 07/06/24 End: 10/31/25 Due: 10/31/26

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06314971 Org: User:
Start: 03/15/23 End: 06/18/26 Due: 06/18/27

Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT01043003 Org: User:
Start: 08/31/06 End: 11/30/11 Due: 11/30/12

Gene Transfer for HIV Using Autologous T Cells

Phase: N/A Priority: Normal
NCT ID: NCT01153646 Org: User:
Start: 04/30/10 End: 01/31/11 Due: 01/31/12

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00540982 Org: User:
Start: 12/31/96 End: 05/20/10 Due: 05/20/11

Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04961320 Org: User:
Start: 07/15/22 End: 06/01/24 Due: 06/01/25

Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00823732 Org: User:
Start: 10/31/08 End: 10/31/14 Due: 10/31/15

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT00002901 Org: User:
Start: 12/31/96 End: - Due: -

Stomach Cancer Exosome-based Detection

Phase: N/A Priority: Normal
NCT ID: NCT06342427 Org: User:
Start: 03/15/23 End: 06/15/24 Due: 06/15/25

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03975231 Org: User:
Start: 09/14/20 End: 10/04/25 Due: 10/04/26

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05800405 Org: User:
Start: 07/20/23 End: 10/20/25 Due: 10/20/26